JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

Home・Aandelen Lijst・Evolent Health Inc

Evolent Health Inc

Gesloten

SectorGezondheidszorg

3.22 -5.01

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.21

Max

3.4699999999999998

Belangrijke statistieken
By Trading Economics
Inkomsten	30M -21M
Verkoop	35M 480M
Winstmarge	-4.351
Werknemers	4,500
EBITDA	512K 15M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+151.48% upside

Dividenden
By Dow Jones
Volgende Winsten	19 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-349M 430M
Vorige openingsprijs	8.23
Vorige sluitingsprijs	3.22

Nieuwssentiment

By Acuity

25%

75%

47 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

10.33 / 10.95 Steun & Weerstand

Evolent Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 jan 2026, 23:07 UTC

Winsten

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 jan 2026, 21:27 UTC

Winsten

Texas Instruments 4Q Sales Rise, Profit Falls

27 jan 2026, 23:55 UTC

Marktinformatie

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 jan 2026, 23:47 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

27 jan 2026, 23:47 UTC

Marktinformatie

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 jan 2026, 23:39 UTC

Marktinformatie

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 jan 2026, 23:20 UTC

Winsten

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 jan 2026, 23:20 UTC

Winsten

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 jan 2026, 23:19 UTC

Winsten

SK Innovation Posts Net Loss for Second Consecutive Year

27 jan 2026, 23:19 UTC

Winsten

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 jan 2026, 23:18 UTC

Winsten

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 jan 2026, 23:18 UTC

Winsten

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 jan 2026, 23:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

27 jan 2026, 23:11 UTC

Marktinformatie

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 jan 2026, 23:07 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 jan 2026, 22:17 UTC

Marktinformatie

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 jan 2026, 22:06 UTC

Winsten

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 jan 2026, 21:51 UTC

Winsten

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

27 jan 2026, 21:43 UTC

Winsten

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 jan 2026, 21:41 UTC

Winsten

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 jan 2026, 21:38 UTC

Winsten

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 jan 2026, 21:32 UTC

Winsten

Ampol: Modest Profit From F&I International in 2025

27 jan 2026, 21:32 UTC

Winsten

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 jan 2026, 21:31 UTC

Winsten

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 jan 2026, 21:31 UTC

Winsten

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 jan 2026, 21:30 UTC

Winsten

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 jan 2026, 21:29 UTC

Winsten

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 jan 2026, 21:29 UTC

Winsten

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 jan 2026, 21:28 UTC

Winsten

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Peer Vergelijking

Prijswijziging

Evolent Health Inc Prognose

Koersdoel

By TipRanks

151.48% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 9.33 USD 151.48%

Hoogste 16 USD

Laagste 5 USD

Gebaseerd op 14 Wall Street-analisten die 12-maands prijsdoelen bieden voor Evolent Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

14 ratings

Buy

Hold

Sell

Gebaseerd op 14 analisten die aandelenratings hebben gegeven aan Evolent Health Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

10.33 / 10.95Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

47 / 352 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.